Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SELECTIS HEALTH, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
3.13
3.62
6.93
20.9
29.3
40.6
36.8
39.5
41.4
General and administrative
1.79
1
1.18
1.3
2.09
5.91
7.87
9.97
9.25
8.89
Operating expenses
2.92
2.67
3.28
5.63
17.6
30
40.9
45.7
42.2
43
Operating income
-0.06
0.46
0.34
1.3
3.37
-0.73
-0.29
-8.96
-2.73
-1.56
Interest expense
-2.58
2.21
2.14
2.14
2.14
2.5
2.23
2.17
2.05
1.73
Interest income
-0.03
0.01
0.03
0.06
0
Other non-operating income
1.23
3.47
2.35
2.17
-0.41
-1.51
-2.11
4.99
0.31
0.55
Pre-tax income
-2.42
-1.01
Income tax
0
Net income to minority interests
-0.14
-0.01
-0.01
-0.01
0.01
0.01
Net income
-1.15
-3
-1.99
-0.86
2.96
-2.25
-2.4
-3.97
-2.42
-1.02
EBITDA
1.41
1.7
1.6
2.65
4.96
1
1.51
-7.29
-1.16
-0.09
EPS, basic
-0.43
-1.04
-0.69
-0.26
1.07
-0.82
-0.79
-1.31
-0.80
-0.34
EPS, diluted
-0.43
-1.04
-0.69
-0.26
0.95
-0.82
-0.79
-1.31
-0.80
-0.34
Shares, basic (weighted)
2.7
2.99
3.12
3.16
2.72
2.77
3.05
3.05
3.07
3.07
Shares, diluted (weighted)
2.7
2.99
3.12
3.16
3.11
2.77
3.05
3.05
3.07
3.07
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0.58
0.15
1.1
0.64
3.57
3.94
1.42
1.48
0.68
1.01
Receivables
1.93
3.51
2.9
2.09
2.62
2.28
Other current assets
0.22
0.54
0.67
0.55
0.68
0.5
0.64
1.38
0.23
0.15
Total current assets
6.21
7.97
4.96
4.96
3.53
7.58
Property, plant and equipment
36.2
36.4
35.9
36.4
38.2
37
35.5
33.8
28.1
23.1
Goodwill
0.38
1.08
1.08
1.08
1.08
1.08
1.08
Intangible assets
0.02
Total assets
37.5
38.2
38.3
39.9
45.9
46.9
42.5
40.7
33.4
32.6
Accounts payable
0.59
3.2
4.36
3.64
6.05
6.57
6.29
Short-term debt
31.7
34.3
35.6
37
1.12
0.15
2.3
11.2
13
17.5
Total current liabilities
23.6
11.8
6.85
18.1
19.6
25.7
Long-term debt
18.8
31.1
34.4
25.2
19.1
13.4
Total liabilities
33
35.9
37.3
39.5
42.7
43.8
41.5
43.6
38.9
39.2
Total debt
32
35.1
36.6
38
19.3
6.31
36.7
36.3
19.1
24.3
Paid-in capital
8.71
9.42
10.1
10.4
11.5
13.5
13.8
13.9
13.9
14.1
Retained earnings
-6.02
-9.05
-11.1
-12
-9.04
-11.3
-13.7
-17.7
-20.2
-21.2
Shareholders' equity
4.71
2.47
1.18
0.57
3.41
3.1
0.95
-2.96
-5.81
-6.61
Minority interests
-0.18
-0.18
-0.2
-0.2
-0.2
Total equity
4.53
2.28
0.98
0.37
3.22
3.1
0.95
-2.96
-5.81
-6.61
Total liabilities and equity
37.5
38.2
38.3
39.9
45.9
46.9
42.5
40.7
33.4
32.6
Shares outstanding
2.9
3.05
3.1
3.18
2.69
3
3.07
3.07
3.07
3.07
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-1.29
-3
-2.01
-0.87
2.96
-2.24
-2.4
-3.97
-2.42
-1.02
Depreciation and amortization
1.47
1.24
1.26
1.35
1.58
1.73
1.79
1.67
1.57
1.47
Stock-based compensation
0.14
0.28
-0.01
0.02
Change in receivables
-0.13
-0.44
-0.49
-2.47
-0.76
-0.66
-1.57
-0.54
Change in payables
0.77
0.09
0.13
0.25
-0.1
2.11
-1.65
2.4
0.53
0.29
Cash from operations
-0.51
0.22
0.11
0.87
2.73
-0.27
-0.31
0.54
-1.82
1.88
Capital expenditures
-0.31
-0.86
-0.76
-1.67
-0.99
-0.52
-0.22
-0.03
-0.04
-0.44
Acquisitions
-0.73
-1.05
Purchases of investments
-0.01
Sales and maturities of investments
0.27
0.15
Cash from investing
2.22
-1.24
-0.6
-2.41
-1.57
-0.52
-0.22
-0.03
2.45
-0.44
Debt issued
0.15
1.18
2.05
1.8
3.37
9.13
Stock issued
0.71
Share buybacks
-0.13
-0.1
Cash from financing
-1.21
0.84
0.82
1.22
1.82
1.61
-1.85
-0.62
-1.54
-0.98
Net change in cash
0.51
-0.19
0.34
-0.31
2.99
0.81
-2.38
-0.11
-0.91
0.46
Free cash flow
-0.82
-0.64
-0.66
-0.8
1.75
-0.79
-0.53
0.51
-1.86
1.44
Interest paid
2.04
2.02
1.88
2.02
2.02
2.5
1.57
1.78
1.75
1.66
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.72 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-12.5%
Operating income / revenue.
Net margin
44.9%
Net income / revenue.
FCF margin
-11.9%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-10.5%
Cash from operations / revenue.
Return on equity (ROE)
183.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
46.4%
Net income / average total assets.
Return on invested capital (ROIC)
-18.6%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue
1.4%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
4.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
0.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
14.6%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y
-7.2%
Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 5y
-3.8%
Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-2.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-8.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-6.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-0.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.02x
Current assets / current liabilities.
Quick ratio
0.78x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.66x
(Cash + short-term investments) / current liabilities.
Debt / equity
2.13x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
54.1%
Total debt / total assets.
Liabilities / assets
74.6%
Total liabilities / total assets.
Net debt
$9.3M
Total debt - cash - short-term investments. Negative means more cash than debt.
Free cash flow / net income, when net income is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$4.23
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$9.42
Revenue / diluted weighted shares.
FCF per share
-$1.12
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.98
Cash from operations / diluted weighted shares.
Book value per share
$2.60
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
1.20x
Market cap / net income. Only when net income is positive.
P/S
0.54x
Market cap / revenue.
P/B
2.20x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.31x
Market cap / tangible book value, when positive.
EV/Sales
0.82x
Enterprise value / revenue.
FCF yield
-22.1%
Free cash flow / market cap.
Earnings yield
83.2%
Net income / market cap (the inverse of P/E).
What was SELECTIS HEALTH, INC.'s revenue in fiscal 2025?
SELECTIS HEALTH, INC. reported revenue of $41.4M for fiscal 2025, 4.9% higher than the year before.
Was SELECTIS HEALTH, INC. profitable in fiscal 2025?
No. It reported a net loss of $1.0M.
How much free cash flow did SELECTIS HEALTH, INC. generate in fiscal 2025?
Cash from operations of $1.9M minus capital expenditures of $443.6K left free cash flow of $1.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.